David Fajgenbaum: Did you know behind every FDA approved drug lies numerous potential disease applications considered by drug companies?
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:
“Did you know behind every FDA approved drug lies numerous potential disease applications considered by drug companies?
This leaves a treasure trove of opportunities on the table, as these medications could offer new hope for a myriad of diseases that currently lack effective treatments.
At Every Cure we want to work with pharmaceutical companies to learn about the other diseases they considered for a certain drug and bring these treatments to as many patients as possible.
By employing advanced data analysis and machine learning, Every Cure is poised to bridge the gap between existing drugs and unmet medical needs. I would love to hear your thoughts on how we can find more uses for existing drugs!”
Video attached to the post.
Source: David Fajgenbaum/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023